FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3179954269> ?p ?o ?g. }

• W3179954269 endingPage "108565" @default.
• W3179954269 startingPage "108565" @default.
• W3179954269 abstract "Evidence-based alcohol-related care-brief intervention for all patients with unhealthy alcohol use and specialty addictions treatment and/or pharmacotherapy for patients with alcohol use disorder (AUD)-should be routinely offered. Transgender persons may be particularly in need of alcohol-related care, given common experiences of social and economic hardship that may compound the adverse effects of unhealthy alcohol use. We examined receipt of alcohol-related care among transgender patients compared to non-transgender patients in a large national sample of Veterans Health Administration (VA) outpatients with unhealthy alcohol use.We extracted electronic health record data for patients from all VA facilities who had an outpatient visit 10/1/09-7/31/17 and a documented positive screen for unhealthy alcohol use (AUDIT-C ≥ 5). We identified transgender patients with a validated approach using transgender-related diagnostic codes. We fit modified Poisson models, adjusted for demographics and comorbidities, to estimate the average predicted prevalence of brief intervention (documented 0-14 days following most recent positive screening), specialty addictions treatment for AUD (documented 0-365 days following screening), and filled prescriptions for medications to treat AUD (documented 0-365 days following screening) for transgender patients, and compared to that of non-transgender patients.Among transgender Veterans with unhealthy alcohol use (N = 1392), the adjusted prevalence of receiving brief intervention was 75.4% (95% CI 72.2-78.5), specialty addictions treatment for AUD was 15.7% (95% CI 13.7-17.7), and any AUD pharmacotherapy was 19.0% (95% CI 17.1-20.8). Receipt of brief intervention did not differ for transgender relative to non-transgender patients (Prevalence Ratio [PR] 1.01, 95% CI 0.98-1.04, p = 0.574). However, transgender patients were more likely to receive specialty addictions treatment (PR 1.24, 95% CI 1.12-1.37, p < 0.001) and pharmacotherapy (PR 1.16, 95% CI 1.06-1.28, p = 0.002).Findings suggest the majority of transgender VHA patients with unhealthy alcohol use receive brief intervention, though a quarter still do not. Nonetheless, rates of specialty addictions treatment and pharmacotherapy are low overall, although transgender patients may be receiving this care at greater rates than non-transgender patients. Further research is needed to investigate these findings and to increase receipt of evidence-based care overall." @default.
• W3179954269 created "2021-07-19" @default.
• W3179954269 creator A5003824803 @default.
• W3179954269 creator A5008920713 @default.
• W3179954269 creator A5010466813 @default.
• W3179954269 creator A5016090548 @default.
• W3179954269 creator A5021476529 @default.
• W3179954269 creator A5024455220 @default.
• W3179954269 creator A5025523111 @default.
• W3179954269 creator A5027786800 @default.
• W3179954269 creator A5051875554 @default.
• W3179954269 creator A5086173094 @default.
• W3179954269 creator A5089202951 @default.
• W3179954269 date "2021-12-01" @default.
• W3179954269 modified "2023-10-17" @default.
• W3179954269 title "Receipt of evidence-based alcohol-related care in a national sample of transgender patients with unhealthy alcohol use: Overall and relative to non-transgender patients" @default.
• W3179954269 cites W1486136249 @default.
• W3179954269 cites W1540050425 @default.
• W3179954269 cites W173705151 @default.
• W3179954269 cites W1923989540 @default.
• W3179954269 cites W1991159980 @default.
• W3179954269 cites W1997840854 @default.
• W3179954269 cites W2000445173 @default.
• W3179954269 cites W2004006565 @default.
• W3179954269 cites W2010430808 @default.
• W3179954269 cites W2025809771 @default.
• W3179954269 cites W2047633694 @default.
• W3179954269 cites W2048597491 @default.
• W3179954269 cites W2051082003 @default.
• W3179954269 cites W2066019849 @default.
• W3179954269 cites W2066059923 @default.
• W3179954269 cites W2069850786 @default.
• W3179954269 cites W2072396944 @default.
• W3179954269 cites W2075663070 @default.
• W3179954269 cites W2079174064 @default.
• W3179954269 cites W2082384879 @default.
• W3179954269 cites W2088761302 @default.
• W3179954269 cites W2101463953 @default.
• W3179954269 cites W2102920679 @default.
• W3179954269 cites W2102976886 @default.
• W3179954269 cites W2103549216 @default.
• W3179954269 cites W2109235191 @default.
• W3179954269 cites W2118836230 @default.
• W3179954269 cites W2121261576 @default.
• W3179954269 cites W2124870273 @default.
• W3179954269 cites W2131939775 @default.
• W3179954269 cites W2138274743 @default.
• W3179954269 cites W2140473247 @default.
• W3179954269 cites W2140956023 @default.
• W3179954269 cites W2143015721 @default.
• W3179954269 cites W2144509036 @default.
• W3179954269 cites W2145516695 @default.
• W3179954269 cites W2154692607 @default.
• W3179954269 cites W2159492208 @default.
• W3179954269 cites W2159574150 @default.
• W3179954269 cites W2165274400 @default.
• W3179954269 cites W2167893882 @default.
• W3179954269 cites W2172137255 @default.
• W3179954269 cites W2231904510 @default.
• W3179954269 cites W2278494219 @default.
• W3179954269 cites W2313049968 @default.
• W3179954269 cites W2418572434 @default.
• W3179954269 cites W2464359699 @default.
• W3179954269 cites W2515705360 @default.
• W3179954269 cites W2526879906 @default.
• W3179954269 cites W2548724077 @default.
• W3179954269 cites W2555058594 @default.
• W3179954269 cites W2564213743 @default.
• W3179954269 cites W2583641410 @default.
• W3179954269 cites W2588470476 @default.
• W3179954269 cites W2594314076 @default.
• W3179954269 cites W2606012276 @default.
• W3179954269 cites W2735913567 @default.
• W3179954269 cites W2737707759 @default.
• W3179954269 cites W2740967155 @default.
• W3179954269 cites W2767190202 @default.
• W3179954269 cites W2795764450 @default.
• W3179954269 cites W2900486088 @default.
• W3179954269 cites W2914580631 @default.
• W3179954269 cites W2940238244 @default.
• W3179954269 cites W2955662239 @default.
• W3179954269 cites W2991046162 @default.
• W3179954269 cites W3000405914 @default.
• W3179954269 cites W3004033261 @default.
• W3179954269 cites W3040494119 @default.
• W3179954269 cites W3127355603 @default.
• W3179954269 cites W4287443032 @default.
• W3179954269 doi "https://doi.org/10.1016/j.jsat.2021.108565" @default.
• W3179954269 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34274175" @default.
• W3179954269 hasPublicationYear "2021" @default.
• W3179954269 type Work @default.
• W3179954269 sameAs 3179954269 @default.
• W3179954269 citedByCount "3" @default.
• W3179954269 countsByYear W31799542692022 @default.
• W3179954269 countsByYear W31799542692023 @default.
• W3179954269 crossrefType "journal-article" @default.
• W3179954269 hasAuthorship W3179954269A5003824803 @default.
• W3179954269 hasAuthorship W3179954269A5008920713 @default.

• next